This paper reports the determination of the X-ray molecular structure of 4-deoxy-3'-bromopyrido[1',2'-1,2]imidazo [5,4-clrifamycin S, carried out in order to unequivocally define the general structure of a new series of rifamycin SV derivatives, which are potent antibacterial agents, and are not absorbed at the gastroenteric level.
Chemical shifts in ppm from TMS as 0, coupling constants in Hz.
The spectra were run on the 200 MHz instrument of the CNR-Research Area of Rome.
X-Ray Crystal Structure
The molecular structure* of 2 is shown in Fig. 2 . The atomic coordinates, bond distances and * The observed amplitudes , calculated structure factors, and atomic thermal parameters are available on request from: The Director, Istituto di Strutturistica Chimica "G. Table 2 . Torsion angles (°) along the skeleton of the ansa-chain, calculated according to the-convention of KLYNE and PRELOG12) . The conformation of the ansa-chain is described by the torsion angles reported in Table 2, together with those of other active rifamycins, such as rifamycin B4), rifampicin5), 3-methoxycarbonylrifamycin S6), and rifamycin SV7).
C(1)-C(2)-N-C(15) C(2)-N-C(15)-C(16) N-C(15)-C(16)-C(17) C(15)-C(16)-C(17)-C(18) C(16)-C(17)-C(18)-C(19) C(17)-C(18)-C(19)-C(20) C(18)-C(19)-C(20)-C(21)
As found in the solid state, the conformation of the ansa-chain from C12 to C17 in 2 is comparable with those mentioned above. It is also similar to those found in solution for many other active ansamycins8), particularly the three-dimensional arrangement of the four oxygen atoms O1, O2, O3 and O10. This arrangement is the feature assumed to be mainly responsible for the compounds' activity9). A different conformation is observed instead along C2-N1-C15-C16. Indeed the lack of the hydrogen atom on N1 and the formation of the double bond between C, and N1, as found in 2, impose different conformational constraints on this junction of the ansa-chain. The coplanarity of the atoms and the bond lengths clearly indicate that there is a large contribution by a mesomeric betaine structure, which suggests that a formal positive charge can be assigned to N1' and a negative charge to N7'.
As a whole the molecular structure observed in the solid state* is stabilized by three intramolecular hydrogen bonds between O1 . . . O2, (2.54 A), O8 . . . O9 (2.69 A), O9 . . . O10 (2.62 A), in which the donors are O2, O9 and O10, respectively. This hydrogen-bonding scheme has already been found both in the solid state6) and in organic solutions for many rifamycin S and SV derivatives8). The intensities of 5281 reflections with 26<54° were measured using monochromatic MoKa radiation (2=0.71069 A) on a Syntex P21 diffractometer, in the w-scan technique, with a variable scan rate between 0.5 and 29.3° minute-1, (depending on the intensity), a scan range of 0.9°, and a background to peak ratio of 0.5. The intensities were corrected for Lorentz and polarization effects, but no correction was made for absorption. During the data collection four standard reflections were monitored every 100 measurements in order to check crystal alignment and stability. Of the 5281 independent reflections collected, 3163 had intensity > 2a(I) and were used in the structure determination.
Experimental
The crystal structure was solved by conventional heavy-atom methods. The atomic coordinates and anisotropic thermal parameters were refined by least-squares calculations in block-diagonal (9 x 9) approximation, to an R * Two water molecules of crystallization , O12 and O13, are linked by a hydrogen bond of 2.74 A. In addition O1 2 acts as donor to O10 (2.87 A) in the same asymmetric unit and to O11 (2.82 A) of a screw-axis related molecule; O 13 is donor to O12 and to O2 (2.91 A) of a third screw-axis related molecule. value of 0.13.
At this stage the oxygen atoms of the water molecules of crystallization and the hydrogen atoms of 2 were found from difference Fourier syntheses.
Refinement was brought to completion keeping the positions of the hydrogen atoms fixed with B values equal to that of the carrier atoms. The final reliability indices are R=0.089 and Rw=0.119.
During refinement the quantity minimized was -7wIFo-Fc12, and the weight assigned to each reflection was w=(a+IFoI+bIFoI2)-1 with a=10.1 and b= 0.007. The atomic scattering factors were taken from the International Tables for X-ray Crystallography").
All the calculations were carried out on the HP-1000 computer of the CNR Research Area of Rome, using a set of programs developed in this Institute")
Conclusions
The similarity in chemical composition and structure of the pyridoimidazo rifamycin S and SV derivatives1), and the similarity of their 1H NMR spectra3), support the assumption that the main features of the molecular structure determined in the crystal on 2 are representative also of those of 1 and of the other related derivatives; that is, all must display analogous betaine structures.
This particular feature is believed to be the main factor determining the pharmacokinetic behavior of these drugs.
In fact, the presence of the phenolic hydroxyls on C1 and C8, and the presence of the opposite charges on N2 and N3 make these molecules ionized at all pH values of the gastroenteric tract, and thus prevent their absorption, which is supposed to take place by a passive mechanism. Derivatives of mycaminosyl tylonolide (1) and 4'-deoxymycaminosyl tylonolide (2) containing N-ethyl-2-fluoro-, 2,2-difluoro-and 2,2,2-trifluoroethylamino groups at their C-23 have been prepared by treating 23-deoxy-23-ethylaminomycaminosyl tylonolide diethyl acetal (14) and its 4'-deoxy analog 15 with 2-fluoro-, 2,2-difluoro-and 2,2,2-trifluoroethyl trifluoromethanesulfonates.
The relationship between the antibacterial activity and the numbers of the fluorine atoms introduced in the final products is discussed. The antibacterial spectra of the above compounds are shown in Table 1 with those of 3 and 4. The results show that, against Gram-positive bacteria, there is not much difference in activity among the compounds including 3 and 4, however, against Gram-negative bacteria and Pseudomonas, a significant gradual decrease in activity is observed with increase of the number of fluorine atoms.
Thus, it is revealed that, for the latter group of bacteria, fluorination of the ,0-position of one of the N-Ethyldifluoroacetamide (5) To a mixture of difluoroacetic acid (7 g), 2,2'-dibenzothiazolyl disulfide (25.4 g), and triphenylphosphine (20 g) in dichloromethane-N,N-dimethylformamide (1: 1, 700 ml) were added 0.95 M ethylamine in acetonitrile (90 ml) and triethylamine (7.7 ml) and the solution was kept at room temp for 5 hours. The solution was washed with aq 2 % hydrochloric acid, aq 2 % sodium hydroxide, water, dried over sodium sulfate, and concentrated. The residue was distilled (4 Torn, bath temp 120°C) to give a syrup of 5, 2.72 g (30%) (Ref6) bp, 60°C); 111 NMR (CDCl3) 6 1.24 (t, 3H, CH3CH2), 3.42 (quintet, 2H, CH3CH2NH), 5.91 (t, IH, 2JH,F=55 Hz, CF2HCO).
N-Ethyl-2,2-difluoroethylamine (6) Compound 5 (2.72 g) was treated with sodium borohydride (2.5 g) and titanium (IV) chloride (6.3 g) similarly as described for 8 to give a liquid of 6, 0.5 g (21 %), by 40°C; 1H NMR (CDCl3) 3 1.14 (t, 3H, CH3CH2), 2.73 (q, 2H, CH3CH2), 2.98 (dt, 2H, CHF2CH2), 5.86 (tt, 1H, CHF2CH2); 3JH-1,H-2 =4 Hz, 3JH-1 ,F=15 Hz, 2JH-2,F=57 Hz.
N-Ethyltrifluoroacetamide (7)
To an ice-cold solution of trifluoroacetic anhydride (15 g) in dry ether (75 ml) was gently introduced ethylamine gas for 10 minutes. The weakly basic solution was concentrated.
The residual syrup was distilled (bp15, bath temp 60°C) to give a syrup of 7, 8.0 g (80 %); 1H NMR (CDCl3) 5 1.24 (t, 3H, CH3CH2NH), 3.43 (quintet, 2H, J=7 Hz, CH3CH2NH), 6~7 (br, IH, NH). N-Ethyl-2,2,2-trifluoroethylamine (8) To a suspension of sodium borohydride (12 g) in dry 1,2-dimethoxyethane (330 ml) was gradually added titanium (IV) chloride (29 g). To the resulting blue solution, a solution of 7 (14.4 g) in 1,2-dimethoxyethane (100 ml) was added, and the mixture was stirred at room temp for 12 hours. Addition of water (1 liter) was followed by aq 28 % ammonia (50 ml) and the reaction mixture was extracted with benzene. The extracts combined were treated with 0.5 M hydrochloric acid and the aq acidic layer separated was concentrated.
To the concentrate (-15 ml), potassium hydroxide was carefully added and the mixture was distilled under atmospheric pressure to give a liquid of 8, 3.9 g (30%), by 66-68°C; 1H NMR (CDCl3) 61.13 (t, 3H, J=7 Hz, CH3CH2), 2.73 (q, 2H, J=7 Hz, CH3CH2), 3.13 (q, 2H, 3JH,F=9 Hz, CF3CH2).
2,2-Difluoroethanol
Prepared from difluoroacetic acid according to HEVNE and PELLEY7), by 95.5~96°C.
2-Fluoroethyl Trifluoromethanesulfonate (9)
To a cold solution (-30°C) of trifluoromethanesulfonyl chloride (15 g) in dichloromethane (15 ml) were added 2-fluoroethanol (2.9 g) and triethylamine (4.6 g), dropwise, in this order, and the mixture was stirred at 0°C for 30 minutes. Cold aq 5 % hydrochloric acid was added untill strongly acidic, and the organic layer separated was dried over sodium sulfate. Evaporation followed by distillation (-12 Torn, bath temp 70°C) gave a liquid of 9, 0.5 g.
2,2-Difluoroethyl Trifluoromethanesulfonate (10)
This was prepared from 2,2-difluoroethanol (2 g of the 66 % solution in ether), trifluoromethanesulfonyl chloride (5 g) in dichloromethane (5 ml), and triethylamine (3.3 g) in a manner as described for 9, 1.66 g (42 %), by 104~ 106°C.
2,2,2-Trifluoroethyl Trifluoromethanesulfonate (11) 2,2,2-Trifluoroethanol (3.3 g) was treated trifluoromethanesulfonyl chloride (5 g) and triethylamine (3.3 g) in a manner as described for 9, and the fraction boiling at 94°C was isolated (3.58 g). The liquid was proved to be a ~ 85 % solution of 11 containing dichloromethane (checked by the 1H NMR spectrum), Refs) bp740 89~91°C (prepared from CF3SO2F and CF3CH2OH).
23-Deoxy-23-ethylaminomycaminosyl Tylonolide Diethyl Acetal (14) To a solution of 122) (110 mg) in dry acetonitrile (2.2 ml) was added 1.55 M ethylamine in acetonitrile (1.1 ml) and the solution was heated at 80°C for 5 hours. Concentration gave a residue, that was dissolved in chloroform, and the solution was washed with satd aq sodium hydrogencarbonate and satd aq sodium sulfate, dried over sodium sulfate and concentrated.
Column chromatography of the concentrate with chloroform -methanol -28 % aq ammonia (15: 1: 0. 23-Deoxy-23-(N-ethyl-2,2-difluoroethylamino)mycaminosyl Tylonolide (19) A mixture of 14 (63 mg), triethylamine (52 mg), and 2,2-difluoroethyl trifluoromethanesulfonate (10, 117 mg of 87.5 % solution in dichloromethane) in dry benzene (0.63 ml) was kept at room temp for 4 hours. After addition of chloroform (6 ml), the solution was treated as described for 16. Column chromatography of the crude product as described for 16 gave a solid of 18, 59 mg (86%). To the solid in acetonitrile (1.2 ml) was added 0.1 M aq hydrochloric acid (2.3 ml) and the solution was treated as described for 17. 23-Deoxy-23-(N-ethyl-2,2,2-trifluoroethylamino)mycaminosyl Tylonolide Diethyl Acetal (22) A mixture of 14 (82 mg), triethylamine (0.13 ml), and 2,2,2-trifluoroethyl trifluoromethanesulfonate (11, 360 mg of 76 % solution in dichloromethane) in dry benzene (0.82 ml) was heated, in a pressure bottle, at 120°C for 2 hours. Concentration gave a residue, that was treated as described for 16 to give, after column chromatography, a solid of 22. Recrystallization from acetone -cyclohexane gave prisms, 64 mg (70%); mp 161-162°C; [a]23D +30° (c 1, CHCl3 Procedure B: A mixture of 15 (3.73 g), triethylamine (3.6 g), and 11 (11.4 g of 67% solution in dichloromethane) in dry benzene -N,N-dimethylformamide (1: 1, 19 ml) was heated at 50°C for 3 hours and then worked up as described for 24 and 25 (Procedure A) to give a solid of 25, 1.67 g (44 based on 15).
